In particular, histone-lysine N-methyltransferase genes KMT2D, KMT2C and KMT2B in bladder, lung and endometrial cancers, whereas the KMT2A is mostly mutated in non-small cell lung cancer and colon cancer. This evidence concerns the gene KMT2A and non-small cell lung carcinoma.